Cargando…
Maternally sequestered therapeutic polypeptides – a new approach for the management of preeclampsia
The last several decades have seen intensive research into the molecular mechanisms underlying the symptoms of preeclampsia. While the underlying cause of preeclampsia is believed to be defective placental development and resulting placental ischemia, it is only recently that the links between the i...
Autores principales: | Bidwell, Gene L., George, Eric M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155872/ https://www.ncbi.nlm.nih.gov/pubmed/25249978 http://dx.doi.org/10.3389/fphar.2014.00201 |
Ejemplares similares
-
A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia
por: Logue, Omar C., et al.
Publicado: (2017) -
Pro-angiogenic therapeutics for preeclampsia
por: Eddy, Adrian C., et al.
Publicado: (2018) -
Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous system
por: McGowan, Jeremy WD, et al.
Publicado: (2016) -
The Natural Polypeptides as Significant Elastase Inhibitors
por: Ahmad, Shabir, et al.
Publicado: (2020) -
The therapeutic potential of antioxidants, ER chaperones, NO and H(2)S donors, and statins for treatment of preeclampsia
por: Cindrova-Davies, Tereza
Publicado: (2014)